Clinical Trials Logo

Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin clinical trials

View clinical trials related to Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin.

Filter by:
  • None
  • Page 1

NCT ID: NCT02449681 Terminated - Clinical trials for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin

Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS

Start date: August 2015
Phase: Phase 2
Study type: Interventional

This phase 2 study is designed to evaluate the safety and activity of TH-4000 (Tarloxotinib), a hypoxia-activated prodrug in participants with recurrent or metastatic squamous cell carcinoma of the head and neck or skin.